MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ACC.23: Cardiovascular Sector Makes Some Noise

The sector is abuzz with clinical data presented at the 2023 American College of Cardiology Scientific Sessions & Expo.

Editor's note: These slides have been updated with key findings presented at the 2023 American College of Cardiology Scientific Sessions & Expo (ACC.23) over the weekend.

As expected, the cardiovascular sector made some noise in New Orleans, LA over the weekend at the 2023 American College of Cardiology Scientific Sessions & Expo (ACC.23).

The following slides cover late-breaking data in transcatheter aortic valve replacement (TAVR), transcatheter tricuspid valve repair (TTVr), pulsed field ablation (PFA), and mechanical thrombectomy for the treatment of pulmonary embolism (PE). The slides also include other recent clinical trial and regulatory news from the TAVR, TTVr, PFA, and mechanical thrombectomy sectors.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish